Among the proposed mechanisms that contribute to tumour escape from the immune system attack is the genetic inactivation of the β2 microglobulin subunit of MHC class 1, which is relatively frequent in several tumour types, including melanomas [22]. This evidence concerns the gene HLA-G and melanoma.